Iannis Elias Adamopoulos, B.Sc(Hons), M.Phil., D.Phil.

Dr. Adamopoulos

Biography: Iannis graduated from the University of Surrey in 1997 and started his research training at University College London in cell biology and cell signaling.  In 2003, he received a DPhil scholarship from Research Into Aging, UK to study the effect of cytokines in the progression of arthritis at Wolfson College, University of Oxford. After a short post-doctoral period at Dr. Teitelbaum’s group in Washington University of Saint Louis, he continued his research on cytokines and autoimmune diseases at the drug discovery program of Schering-Plough Biopharma, California, USA. Dr. Adamopoulos is currently researching novel treatments and therapeutic strategies for inflammatory arthritis and immune bone loss. He also serves as a reviewer for leading journals in rheumatology as well as serving in the scientific advisory board of biotechnology companies.

 

Gurtej S. Cheema, M.D.

Dr. CheemaBiography: Dr. Gurtej S. Cheema went to medical school in India. He completed his residency in Internal Medicine and fellowship in Rheumatology at LAC+USC Medical Center in Los Angeles CA. Dr. Cheema participated in research looking at the role of B lymphocyte stimulator in different autoimmune diseases. This research eventually led to the approval of Belimumab (Benlysta) for use in treatment of systemic lupus. Currently, Dr. Cheema manages patients with all kinds of autimmune conditions ranging from rheumatoid arthritis to vasculitis.

 

M. Eric Gershwin, M.D., M.A.C.P., M.A.C.R.

Dr. M. Eric Gershwin

Biography: Dr. M. Eric Gershwin is a world renowned authority in clinical immunology, including allergy and rheumatology.  He is a "Master" of the American College of Physicians and also a "Master" of the American College of Rheumatology.  He has received numerous international honors, including an honorary doctorate from the University of Athens for lifetime achievement in clinical immunology.  Dr. Gershwin has received the AESKU Prize for lifetime contribution in immunology.  He founded the clinical immunology program at UC Davis in 1975.  He has a long track record of clinical research involving autoimmunity, allergy and immunology.  Dr. Gershwin has published multiple textbooks which are now translated in 7 languages.  He was the first Jack and Donald Chia Endowed Professor recipient at UC Davis in 1994.

Dr. Gershwin has worked extensively on behalf of patients with immunological diseases for many nonprofit organizations.  He has also been a consultant to the FDA, the FTC, the USDA, NIH and DOD.  He has written more than 800 scientific articles and 25 clinical books.  Many of his books are in widespread usage in teaching programs throughout the world.  Dr. Gershwin has been an advisor/consultant for multiple governmental agencies, including Japan, the United Kingdom, Holland, Germany, Italy and Australia.  He also holds several patents in immunology.  Finally, Dr. Gershwin is considered a world expert on environmental health, including such issues as food safety, mold, allergens, asbestos and environmental hazards.

 

Arshia D. Islam, M.D.

Dr. Islam

Biography: It is a privilege to be a part of the Clinical Faculty in the Department of Rheumatology, Allergy and Clinical Immunology.  As a Rheumatologist, I treat systemic autoimmune and inflammatory diseases with special interest in Systemic Lupus Erythematosus, Sarcoidosis, Vasculitis and Inflammatory Arthritis. Working in an academic setting allows me to enjoy the perfect balance of providing the most up-to-date care for my patients, as well as the intellectual stimulation of teaching.

 

Stanley Naguwa, M.D.

Dr. Stanley Naguwa

Biography: Understanding of the immunological cause of diseases was just beginning when I was in residency. The specialty intrigued and challenged me, both then and now. Education is the most important service that I deliver. Patients need knowledge to make the best decisions. I enjoy teaching patients, nurses, students—everyone. I believe in a team approach to medical care and that the patient is a full partner in health-care delivery. UC Davis has a special commitment to teaching and a wealth of resources, including professional and technical expertise, equipment and dedication to excellence.

 

Siba Raychaudhuri, M.D.

Dr. RaychaudhuriBiography: About two decades ago while working as a scientist at Stanford we identified and dissected the role of Nerve Growth Factor (NGF) in inflammation.  With time this fundamental work in molecular medicine has provided a new dimension in understandings of the disease mechanisms in autoimmune diseases. NGF targeted therapies are now in preparation for pain relief and treatment of arthritis. Currently our research focus is to understand the molecular mechanisms of immune mediated inflammatory diseases, with a particular focus on psoriasis and autoimmune arthritis. Our research lab’s overarching goal is to provide the groundwork to streamline, accelerate, and promote the translation of basic discoveries into effective therapies that benefit all patients, including but not limited to Veterans suffering from lifelong chronic autoimmune diseases.

 

Judy Van de Water, Ph.D.

Dr. Van de WaterDr. Van de Water is a well-known immunologist whose primary interests for the past 20 years include autoimmunity, immunopathology, and molecular and cell biology. Dr. Van de Water’s laboratory research programs include the identification of the various mechanisms associated with autoimmune and other immune-mediated disorders. This includes the biological aspects of autism spectrum disorders including immune dysfunction and autoantibody production. In addition, her current work involves the identification of maternal antibodies to fetal brain proteins found in some mothers of children with autism. Moreover, Dr. Van de Water was the Core Director of the Molecular and Cell Biology Core for the NIEHS Center for Children’s Environmental Health, entitled "Environmental Factors in the Etiology of Autism", investigating potential environmental risk factors contributing to the incidence and severity of childhood autism. This project has been renewed and Dr. Van de Water is now the P.I. of Project 2, the Immunological Susceptibility in Autism.  She received her B.S. in Biological Sciences University of California, Davis, in 1978 and her Ph.D. in Immunology form the University of California, Davis, in 1988.

 

Biographies Coming Soon:

Happy Chan, M.D.
Shirin Ahmad, M.D.